Sigma Planning Corp
- SEC CIK
- 0001449126
- Latest filing
- Aug 7, 2026
MBRX holding history
Moleculin Biotech, Inc. in every 13F filed by Sigma Planning Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MBRX overviewAll 13F holders of MBRXFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −800−100.0% | Sold outConverted for a 1-for-15 split | Holders |
| Q4 2023 | 12,000 | $10.3K | <0.1% | −5,000−29.4% | Reduced | Holders |
| Q3 2023 | 17,000 | $7.27K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 17,000 | $9.84K | <0.1% | −40,500−70.4% | Reduced | Holders |
| Q1 2023 | 57,500 | $55.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 57,500 | $61.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 57,500 | $61.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 57,500 | $83.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 57,500 | $102.0K | <0.1% | +14,500+33.7% | Added | Holders |
| Q4 2021 | 43,000 | $80.0K | <0.1% | +43,000 | New | Holders |